 By David Bautz, PhD NASDAQ:CBMG READ THE FULL CBMG RESEARCH REPORT Business Update Cellular Biomedicine Group, Inc. NASDAQ:CBMG is a biopharmaceutical company developing cell-based therapies for cancer and degenerative diseases. The company is currently conducting investigator-initiated trials IIT in China for two of its chimeric antigen receptor CAR-T products as well as a T Cell Receptor 